< > J289 - Journal of Veterinary Pharmacology and Therapeutics

Organisation American College of Veterinary Pharmacology and Therapeutics, the Association for Veterinary Clinical Pharmacology and Therapeutics (UK), and the European Association for Veterinary Pharmacology and Toxicology.
Publisher Blackwell Scientific Publications. Oxford, UK. 1978-
ISSN pISSN: 0140-7783
eISSN: 1365-2885

Specific Chapter/Section References

Ref. Year Authors Title Vol. Pages
J289.1.w1 1978 Waterman, A. & Livingston, A. Studies on the distribution and metabolism of ketamine in sheep  1 141-147
J289.1.w2 1978 Baggot, J.D. Some aspects of clinical pharmacokinetics in veterinary medicine. I 1 5-18
J289.1.w3 1978 Baggot, J.D. Some aspects of clinical pharmacokinetics in veterinary medicine II 1 111-118
J289.2.w1 1979 Eberhardson, B., Olsson, G., Appelgren, L-E. & Jacobsson, S-O. Pharmacokinetic studies of phenylbutazone in cattle 2 31-37
J289.3.w1 1980 De Backer, P., Braeckman, R., Belpaire, F. & Debackere, M. Bioavailability and pharmacokinetics of phenylbutazone in the cow 3 29-33
J289.4.w1 1981 Garcia-Villar, R., Toutain, P.L., Alvinerie, M. & Ruckebush, Y. The pharmacokinetics of xylazine hydrochloride: an interspecific study 4 87-92
J289.7.w1 1984 Martin, K., Andersson, L., Stridsberg, M., Wiese, B. & Appelgren, L.E. Plasma concentration, mammary excretion and side-effects of phenylbutazone after repeated oral administartion in healthy cows 7 131-128
J289.7.w2 1984 Waterman, A. E. The pharmacokinetics of ketamine administered intravenously in calves and the modifying effect of premedication with xylazine hydrochloride 7 125-130
J289.10.w1 1987 Dalvi, R.R., Nunn, V.A. & Juskevich, J. Hepatic cytochrome P-450 dependent drug metabolizing activity in rats, rabbits and several food-producing species 10 164-168
J289.10.w2 1987 Nolan, A., Livingston, A. & Waterman, A. Antinociceptive actions of intravenous α2- adrenoceptor agonists in sheep 10 202-209
J289.11.w1 1988 Nolan, A., Waterman, A. & Livingston, A. The correlation of the thermal and mechanical antinociceptive activity of pethidine hydrochloride with plasma concentrations of the drug in sheep 11 94-102
J289.13.w1 1990 Boudinot, F.D., Williams, R.J. & Smith, J.A. Effect of non-linear plasma protein binding on unbound and total plasma phenylbutazone concentrations in cows 13 132-136
J289.14.w1 1991 Waterman, A.E., Livingston, A. & Amin, A. Further studies on the antinociceptive activity and respiratory effects of buprenorphine in sheep 14 230-234
J289.14.w2 1991 Lohuis, J.A.C.M., Van Werven, T., Brand, A., Van Miert, A.S.J.P.A.M., Rohde, E., Ludwig, B., Heizmann, P. & Rehm, W.F. Pharmacodynamics and pharmacokinetics of carprofen, a non-steroidal anti-inflammatory drug, in health cows and cows with Escherichia coli endotoxin-induced mastitis 14 219-229
J289.14.w3 1991 Ley, S., Waterman, A. & Livingston, A. The influence of chronic pain on the analgesic effects of the a-2 adrenoceptor agonist, xylazine, in sheep. 14 141-144
J289.15.w1 1992 Court, M.H., Dodman, N.H., Levoine, H.D., Richley, M.T., Lee, J.W. & Hustead, D.R. Pharmakokinetics and milk residues of butorphanol in dairy cows after single intravenous administration 15 28-35
J289.16.w1 1993 Welsh, E.M., McKellar, Q.A. & Nolan, A.M. The pharmacokinetics of flunixin meglumine in the sheep 16 181-188
J289.16.w2 1993 Eltom, S.E., Guard, C.L. & Schwark, W.S. The effect of age on phenylbutazone pharmacokinetics, metabolism and plasma protein binding in goats 16 141-151
J289.16.w3 1993 Qiao, G.-L. & Fung, K.-F. Pharmacokinetic-pharmacodynamic modelling of meperidine in goats (I): pharmacokinetics 16 426-437
J289.18.w1 1995 Landoli, M.F., Cunningham, F.M. & Lees, P. Pharmacokinetics and pharmacodynamics of ketoprofen in calves applying PK/PD modelling 18 315-324
J289.18.w2 1995 Odensvik, K. Pharmacokinetics of flunixin and its effect on prostaglandin F concentrations after oral and intravenous administration in heifers 18 254-259
J289.18.w3 1995 Chambers, J.P., Waterman, A.E. & Livingston, A. The effects of opioid and α2 adrenergic blockade on non-steroidal anti-inflammatory drug analgesia in sheep 18 161-166
J289.19.w1 1996 Muge, D.K., Chambers, J.P. & Livingston, A. Single dose pharmacokinetics of medetomidine in sheep 19 109-112
J289.20.w1 1997 Main, D.C.J., Waterman, A.E., Kilpatrick, I.C. & Jones, A. An assessment of the peripheral antinociceptive potential of remoxipride, clonidine and fentanyl in sheep using the forelimb tourniquet 20 220-228
J289.20.w2 1997 Landoni, M.F., Soraci, A.L., Delatour, P. & Lees, P. Enantioselective behaviour of drugs used in domestic animals: a review 20 1-16
J289.20.w3 1997 Reding, J., Sahin, A., Schlatter, J. & Naegeli, H. Dexamethasone and flumethasone residues in milk of intramuscularly doses cows 20 198-203
J289.21.w1 1998 Musser, J.M.B., Anderson, K.L. & Tyczkowska, K.L. Pharmakokinetic parameters and milk concentrations of ketoprofen after administration as a single intravenous bolus dose to lactating goats 21 358-363
J289.21.w2 1998 Cheng, Z., McKeller, Q. & Nolan, A. Pharmacokinetic studies of flunixin meglumine and phenylbutazone in plasma, exudate and transudate in sheep 21 315-321
J289.21.w3 1998 Chamberlain, P.L. & Brynes, S.D. The regulatory status of xylazine for food-producing animals in the United States 21 322-329
J289.22.w1 1999 Landoni, M.F., Comas, W., Mucci, N., Anglarilli, G., Bidal, D. & Lees, P. Enantiospecific pharmacokinetics and pharmacodynamics of ketoprofen in sheep 22 349-359
J289.23.w1 2000 Fthenakis, G.C. Field evaluation of flunixin meglumine in the supportive treatment of ovine mastitis 23 405-407
J289.24.w1 2001 Amiridis, G.S., Leontides, L., Tassos, E., Kostulas, P. & Fthenakis, G.C. Flunixin meglumine accelerates uterine involution and shortens the calving-to-first-oestrus interval in cows with puerperal mastitis 24 365-367
J289.25.w1 2002 Arifah, A.K. & Lees, P. Pharmacodynamics and pharmacokinetics of phenylbutazone in calves 25 299-309
J289.25.w2 2002 De Veau, I.F., Pedersoli, W., Cullison, R. & Baker, J. Pharmakokinetics of phenylbutazone in beef steers 25 195-200
J289.25.w3 2002 Rantala, M., Kaartinen, L., Valimaki, E., Stryrman, M., Hiekkaranta, M., Niemi, A., Saari, L. & Pyorala, S. Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis 25 251-258
J289.26.w1 2003 Arifah, A.K., Landoni, M.F. & Lees, P. Pharmacodynamics, chiral pharmacokinetics and PK-PD modelling of ketoprofen in the goat 26 139-150
J289.26.w2 2003 Cheng, Z., Nolan, A., Monteiro, A. & McKellar, Q. Enantioselective pharmacokinetics and cyclo-oxygenase inhibition of carprofen and carprofen enantiomers in sheep 26 391-394
J289.27S1.w1 2004 USP (United States Pharmacopeia) Veterinary Medicine Expert Committee USP Veterinary Pharmaceutical Information Monographs - Anti-inflammatories 27S1 1-110
J289.28.w1 2005 Maslow, J.N., Mikota, S.K., Zhu, M., Riddle, H. & Peloquin, C.A. Pharmakokinetics of ethambutol (EMB) in elephants 28 321-323
J289.28.w2 2005 Zhu, M., Maslow, J.N., Mikota, S.K., Isaza, R., Dunker, F., Riffle, H. & Peloquin, C.A. Population pharmacokinetics of pyrazinamide in elephants 28 403-409
J289.28.w3 2005 Maslow, J.N., Mikota, S.K., Zhu, M., Isaza, R., Peddie, L.R., Dunker, F., Peddie, J., Riddle, H. & Peloquin, C.A. Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana) 28 21-27

Return to top of page